184 related articles for article (PubMed ID: 27094343)
1. Oral quercetin administration transiently protects respiratory function in dystrophin-deficient mice.
Selsby JT; Ballmann CG; Spaulding HR; Ross JW; Quindry JC
J Physiol; 2016 Oct; 594(20):6037-6053. PubMed ID: 27094343
[TBL] [Abstract][Full Text] [Related]
2. Nutraceutical and pharmaceutical cocktails did not improve muscle function or reduce histological damage in D2-mdx mice.
Spaulding HR; Quindry T; Hammer K; Quindry JC; Selsby JT
J Appl Physiol (1985); 2019 Oct; 127(4):1058-1066. PubMed ID: 31295065
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Quercetin Dietary Enrichment Partially Protects Dystrophic Skeletal Muscle.
Spaulding HR; Ballmann CG; Quindry JC; Selsby JT
PLoS One; 2016; 11(12):e0168293. PubMed ID: 27977770
[TBL] [Abstract][Full Text] [Related]
4. Long-term quercetin dietary enrichment decreases muscle injury in mdx mice.
Hollinger K; Shanely RA; Quindry JC; Selsby JT
Clin Nutr; 2015 Jun; 34(3):515-22. PubMed ID: 24998094
[TBL] [Abstract][Full Text] [Related]
5. Long-term dietary quercetin enrichment as a cardioprotective countermeasure in mdx mice.
Ballmann C; Denney T; Beyers RJ; Quindry T; Romero M; Selsby JT; Quindry JC
Exp Physiol; 2017 Jun; 102(6):635-649. PubMed ID: 28192862
[TBL] [Abstract][Full Text] [Related]
6. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
7. Nutraceutical and pharmaceutical cocktails did not preserve diaphragm muscle function or reduce muscle damage in D2-mdx mice.
Spaulding HR; Quindry T; Quindry JC; Selsby JT
Exp Physiol; 2020 Jun; 105(6):989-999. PubMed ID: 32267561
[TBL] [Abstract][Full Text] [Related]
8. Lifelong quercetin enrichment and cardioprotection in Mdx/Utrn+/- mice.
Ballmann C; Denney TS; Beyers RJ; Quindry T; Romero M; Amin R; Selsby JT; Quindry JC
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H128-H140. PubMed ID: 27836895
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
[TBL] [Abstract][Full Text] [Related]
11. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
12. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
[TBL] [Abstract][Full Text] [Related]
13. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice.
Fogagnolo Mauricio A; Minatel E; Santo Neto H; Marques MJ
Clin Nutr; 2013 Aug; 32(4):636-42. PubMed ID: 23218947
[TBL] [Abstract][Full Text] [Related]
14. Rescue of dystrophic skeletal muscle by PGC-1α involves restored expression of dystrophin-associated protein complex components and satellite cell signaling.
Hollinger K; Gardan-Salmon D; Santana C; Rice D; Snella E; Selsby JT
Am J Physiol Regul Integr Comp Physiol; 2013 Jul; 305(1):R13-23. PubMed ID: 23594613
[TBL] [Abstract][Full Text] [Related]
15. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
[TBL] [Abstract][Full Text] [Related]
16. Histological and biochemical outcomes of cardiac pathology in mdx mice with dietary quercetin enrichment.
Ballmann C; Hollinger K; Selsby JT; Amin R; Quindry JC
Exp Physiol; 2015 Jan; 100(1):12-22. PubMed ID: 25557727
[TBL] [Abstract][Full Text] [Related]
17. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
18. Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology.
Reay DP; Yang M; Watchko JF; Daood M; O'Day TL; Rehman KK; Guttridge DC; Robbins PD; Clemens PR
Neurobiol Dis; 2011 Sep; 43(3):598-608. PubMed ID: 21624467
[TBL] [Abstract][Full Text] [Related]
19. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
[TBL] [Abstract][Full Text] [Related]
20. Loss of compensation afforded by accessory muscles of breathing leads to respiratory system compromise in the mdx mouse model of Duchenne muscular dystrophy.
O'Halloran KD; Maxwell MN; Marullo AL; Hamilton CP; Ó Murchú SC; Burns DP; Mahony CM; Slyne AD; Drummond SE
J Physiol; 2023 Oct; 601(19):4441-4467. PubMed ID: 37688347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
